Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 30 November 2006. doi:10.1136/bjsm.2006.030239
British Journal of Sports Medicine 2007;41:134-139
Copyright © 2007 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine.

ORIGINAL ARTICLE

Topical ketoprofen TDS patch versus diclofenac gel: efficacy and tolerability in benign sport related soft-tissue injuries

Francisco Esparza1, César Cobián2, José Fernando Jiménez3, Juan José García-Cota4, Carlos Sánchez5, Antonio Maestro6, the working group for the acute pain study of SETRADE (coordinated by Josep Borrell)

1 Centro Médico Juan XXIII, Murcia, Spain
2 Hospital Modelo, La Coruña, Spain
3 Centro de Medicina General y Deporte, Toledo, Spain
4 Hospital Miguel Domínguez, Pontevedra, Spain
5 Servicios Médicos de la Autoridad Portuaria de Valencia, Spain
6 Sanatorio Begoña, Gijón, Spain and SETRADE (Spanish Society of Sports Traumatology), Barcelona, Spain

Correspondence to:
Profesor F Esparza
Cátedra de Traumatología del Deporte, Facultad de Ciencias de la Salud y del Deporte, Universidad Católica San Antonio de Murcia, Campus de los Jerónimos s/n, 30107 Guadalupe (Murcia), Spain; fesparza{at}pdi.ucam.edu

Objective: To compare the ketoprofen TDS patch with diclofenac gel in the treatment of traumatic acute pain in benign sport-related soft-tissue injuries.

Design: 7–14 treatment days, prospective, randomised, open study.

Patients: Outpatients aged 18–70 years diagnosed for painful benign sport-related soft-tissue injury (sprains, strains and contusions within the prior 48 h), randomised to either ketoprofen patch 100 mg once daily (n = 114) or diclofenac gel 2–4 g three times daily (n = 109).

Intervention: 7–14 days of topical non-steroidal anti-inflammatory drugs treatment to assess the pain intensity changes (daily activities and spontaneous at rest) in a daily diary (100-mm Visual Analogue Scale (VAS)).

Main outcome measurement: Pain intensity (VAS).

Results: The ketoprofen patch was not inferior to diclofenac gel in reducing the baseline pain during daily activities (difference of –1.17 mm in favour of ketoprofen patch, 95% CI (–5.86 to 3.52), reducing to the baseline VAS 79%. Ketoprofen patch presented also a higher cure rate (64%) than diclofenac gel (46%) at day 7 (p = 0.004). Patient opinions about the treatment comfort (pharmaceutical shape, application and dosage) were also statistically higher for the ketoprofen patch (>80% of the patients rated as good or excellent the patch removal and skin adherence).

Conclusion: Ketoprofen patches are effective and safe pain relievers for the treatment of sports injury pain with advantages compared with diclofenac gel.

Abbreviations: LOCF, last observation carried forward; NSAID, non-steroidal anti-inflammatory drug; VAS, Visual Analogue Scale


 

COMMENTARY

Dwight Santiago7

7 Ashford Medical Centre, San Juan, PR, USA; drsan{at}prtc.net


 

COMMENTARY

Manuel Cusi8

8 Orthosports, Strathfield, Australia; m.cusi{at}unsw.edu.au


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

 

The journal is co-owned by and the official journal of BASEM

Official journal of ECOSEP

Available online to all members of ACSP, AMSSM and SMNZ